+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macular Degeneration"

Ophthalmic Equipment Market Overview, 2025-30 - Product Thumbnail Image

Ophthalmic Equipment Market Overview, 2025-30

  • Report
  • March 2025
  • 110 Pages
  • Global
From
Middle East & Africa Ophthalmic Equipment Market Outlook, 2030 - Product Thumbnail Image

Middle East & Africa Ophthalmic Equipment Market Outlook, 2030

  • Report
  • March 2025
  • 82 Pages
  • Middle East, Africa
From
From
Asia-Pacific Ophthalmic Equipment Market Outlook, 2030 - Product Thumbnail Image

Asia-Pacific Ophthalmic Equipment Market Outlook, 2030

  • Report
  • March 2025
  • 96 Pages
  • Asia Pacific
From
Europe Ophthalmic Equipment Market Outlook, 2030 - Product Thumbnail Image

Europe Ophthalmic Equipment Market Outlook, 2030

  • Report
  • March 2025
  • 99 Pages
  • Europe
From
North America Ophthalmic Equipment Market Outlook, 2030 - Product Thumbnail Image

North America Ophthalmic Equipment Market Outlook, 2030

  • Report
  • March 2025
  • 88 Pages
  • North America
From
From
From
From
From
Cell and Gene Therapies in Ophthalmology - Product Thumbnail Image

Cell and Gene Therapies in Ophthalmology

  • Report
  • March 2024
  • 44 Pages
  • Global
From
From
Loading Indicator

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision. Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more